Revolution Medicines, Inc. Capital Expenditures Incurred but Not yet Paid
Revolution Medicines, Inc. (RVMD) reported Capital Expenditures Incurred but Not yet Paid of $3.78 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2026-08-05
- Revolution Medicines, Inc. capital expenditures incurred but not yet paid for the quarter ending 2026-06-30 was $3.00M, a 2354.92% increase year-over-year.
- Revolution Medicines, Inc. capital expenditures incurred but not yet paid for the quarter ending 2026-03-31 was $786.00K, a 71.78% decline year-over-year.
- Revolution Medicines, Inc. capital expenditures incurred but not yet paid for the quarter ending 2025-12-31 was $454.00K, a 52.71% decline year-over-year.
- Revolution Medicines, Inc. capital expenditures incurred but not yet paid for the quarter ending 2025-09-30 was -$1.49M.
- Revolution Medicines, Inc. capital expenditures incurred but not yet paid for fiscal 2025 was $1.88M, a 19.04% increase from fiscal 2024.
- Revolution Medicines, Inc. capital expenditures incurred but not yet paid for fiscal 2024 was $1.58M, a 39.64% decline from fiscal 2023.
- Revolution Medicines, Inc. capital expenditures incurred but not yet paid for fiscal 2023 was $2.61M, a 84.00% increase from fiscal 2022.
- Revolution Medicines, Inc. capital expenditures incurred but not yet paid for fiscal 2022 was $1.42M, a 25.69% increase from fiscal 2021.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $3.78M 10-Q · filed 2026-08-05 | $4.24M derived: sum of 3 quarters · filed 2026-08-05 | $2.75M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $786.00K 10-Q · filed 2026-05-06 | $1.24M derived: sum of 2 quarters · filed 2026-05-06 | -$245.00K derived: sum of 3 quarters · filed 2026-05-06 | -$123.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $454.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$1.03M derived: sum of 2 quarters · filed 2026-02-25 | -$909.00K derived: sum of 3 quarters · filed 2026-08-05 | $1.88M 10-K · filed 2026-02-25 |
| 2025-09-30 | -$1.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$1.36M derived: sum of 2 quarters · filed 2026-08-05 | $1.42M 10-Q · filed 2025-11-05 | $2.38M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $122.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $2.91M 10-Q · filed 2026-08-05 | $3.87M derived: sum of 3 quarters · filed 2026-08-05 | $1.72M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $2.79M 10-Q · filed 2026-05-06 | $3.75M derived: sum of 2 quarters · filed 2026-05-06 | $1.60M derived: sum of 3 quarters · filed 2026-05-06 | $2.47M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $960.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$1.19M derived: sum of 2 quarters · filed 2026-02-25 | -$313.00K derived: sum of 3 quarters · filed 2026-02-25 | $1.58M 10-K · filed 2026-02-25 |
| 2024-09-30 | -$2.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$1.27M derived: sum of 2 quarters · filed 2025-11-05 | $616.00K 10-Q · filed 2025-11-05 | $1.90M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $873.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $2.76M 10-Q · filed 2025-08-06 | $4.04M derived: sum of 3 quarters · filed 2026-02-25 | $3.34M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $1.89M 10-Q · filed 2025-05-07 | $3.17M derived: sum of 2 quarters · filed 2026-02-25 | $2.47M derived: sum of 3 quarters · filed 2026-02-25 | $3.76M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $1.28M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $581.00K derived: sum of 2 quarters · filed 2026-02-25 | $1.87M derived: sum of 3 quarters · filed 2026-02-25 | $2.61M 10-K · filed 2026-02-25 |
| 2023-09-30 | -$701.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $585.00K derived: sum of 2 quarters · filed 2024-11-06 | $1.33M 10-Q · filed 2024-11-06 | -$6.00K derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-06-30 | $1.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $2.03M 10-Q · filed 2024-08-07 | $695.00K derived: sum of 3 quarters · filed 2025-02-26 | $519.00K derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-03-31 | $744.00K 10-Q · filed 2024-05-08 | -$591.00K derived: sum of 2 quarters · filed 2025-02-26 | -$767.00K derived: sum of 3 quarters · filed 2025-02-26 | $491.00K derived: sum of 4 quarters · filed 2025-02-26 |
| 2022-12-31 | -$1.33M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | -$1.51M derived: sum of 2 quarters · filed 2025-02-26 | -$253.00K derived: sum of 3 quarters · filed 2025-02-26 | $1.42M 10-K · filed 2025-02-26 |
| 2022-09-30 | -$176.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $1.08M derived: sum of 2 quarters · filed 2023-11-06 | $2.75M 10-Q · filed 2023-11-06 | $3.84M derived: sum of 4 quarters · filed 2024-02-26 |
| 2022-06-30 | $1.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $2.93M 10-Q · filed 2023-08-08 | $4.01M derived: sum of 3 quarters · filed 2024-02-26 | $3.82M derived: sum of 4 quarters · filed 2024-02-26 |
| 2022-03-31 | $1.67M 10-Q · filed 2023-05-08 | $2.76M derived: sum of 2 quarters · filed 2024-02-26 | $2.56M derived: sum of 3 quarters · filed 2024-02-26 | $1.92M derived: sum of 4 quarters · filed 2024-02-26 |
| 2021-12-31 | $1.08M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | $891.00K derived: sum of 2 quarters · filed 2024-02-26 | $247.00K derived: sum of 3 quarters · filed 2024-02-26 | $1.13M 10-K · filed 2024-02-26 |
| 2021-09-30 | -$194.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | -$838.00K derived: sum of 2 quarters · filed 2022-11-07 | $44.00K 10-Q · filed 2022-11-07 | $1.42M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | -$644.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $238.00K 10-Q · filed 2022-08-09 | $1.61M derived: sum of 3 quarters · filed 2023-02-27 | $1.52M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | $882.00K 10-Q · filed 2022-05-09 | $2.25M derived: sum of 2 quarters · filed 2023-02-27 | $2.17M derived: sum of 3 quarters · filed 2023-02-27 | $2.66M derived: sum of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | $1.37M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $1.28M derived: sum of 2 quarters · filed 2023-02-27 | $1.78M derived: sum of 3 quarters · filed 2023-02-27 | $1.81M 10-K · filed 2023-02-27 |
| 2020-09-30 | -$89.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $404.00K derived: sum of 2 quarters · filed 2021-11-10 | $441.00K 10-Q · filed 2021-11-10 | $567.00K derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $493.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $530.00K 10-Q · filed 2021-08-11 | $656.00K derived: sum of 3 quarters · filed 2022-02-28 | $0.00 derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $37.00K 10-Q · filed 2021-05-10 | $163.00K derived: sum of 2 quarters · filed 2022-02-28 | -$493.00K derived: sum of 3 quarters · filed 2022-02-28 | $179.00K derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $126.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$530.00K derived: sum of 2 quarters · filed 2022-02-28 | $142.00K derived: sum of 3 quarters · filed 2022-02-28 | $380.00K 10-K · filed 2022-02-28 |
| 2019-09-30 | -$656.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $16.00K derived: sum of 2 quarters · filed 2020-11-12 | $254.00K 10-Q · filed 2020-11-12 | |
| 2019-06-30 | $672.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $910.00K 10-Q · filed 2020-08-10 | ||
| 2019-03-31 | $238.00K 10-Q · filed 2020-05-14 | |||
| 2018-12-31 | $233.00K 10-K · filed 2021-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |